6864 Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 

1. Negotiate written agreements with 

the other agencies participating in the 

matching programs; 

2. Obtain the Data Integrity Board 

approval of the match agreements; 

3. Furnish detailed reports about 

matching programs to Congress and 

OMB; 

4. Notify applicants and beneficiaries 

that the records are subject to matching; 

and, 

5. Verify match findings before 

reducing, suspending, terminating, or 

denying an individual’s benefits or 

payments. 

This matching program meets the 

requirements of the Privacy Act of 1974, 

as amended. 

Celeste Dade-Vinson, 

Health Insurance Specialist, Centers for 

Medicare & Medicaid Services. 

CMS Computer Match No. 2016–12 

HHS COMPUTER MATCH NO. 1604

SSA COMPUTER MATCH NO. 1097–1899

NAME: 

‘‘Computer Matching Agreement 

between the Department of Health and 

Human Services, Centers for Medicare & 

Medicaid Services and the Social 

Security Administration for 

Determining Enrollment or Eligibility 

for Insurance Affordability Programs 

under the Patient Protection and 

Affordable Care Act’’ 

SECURITY CLASSIFICATION: 

Unclassified 

PARTICIPATING AGENCIES: 

Department of Health and Human 

Services (HHS), Centers for Medicare & 

Medicaid Services (CMS), and the 

Social Security Administration (SSA) 

AUTHORITY FOR CONDUCTING MATCHING

PROGRAM: 

Sections 1411 and 1413 of the Patient 

Protection and Affordable Care Act of 

2010 (Pub. L. 111–148), as amended by 

the Health Care and Education 

Reconciliation Act of 2010 (Pub. L. 111– 

152) (collectively, the ACA) require the 

Secretary of HHS to establish a program 

for determining eligibility for certain 

state health subsidy programs, and 

certifications of Exemption; and 

authorize use of secure, electronic 

interfaces and an on-line system for the 

verification of eligibility. 

PURPOSE(S) OF THE MATCHING PROGRAM: 

The purpose of the Computer 

Matching Agreement (CMA) is to reestablish the terms, conditions, 

safeguards, and procedures under which 

SSA will disclose information to CMS 

in connection with the administration of 

state health subside programs under the 

ACA and its implementing regulations. 

SSA will provide data to CMS, and CMS 

will use SSA data needed to make 

initial eligibility determinations, 

eligibility redeterminations and renewal 

decisions, including appeal 

determinations, for state health subsidy 

programs and certifications of 

exemption. State health subsidy 

programs include: 

1. Qualified Health Plan through an 

Exchange established under the ACA, 

2. Advance payments of the premium 

tax credit and cost sharing reductions, 

3. Medicaid, 

4. Children’s Health Insurance 

Program, and 

5. Basic Health Program. 

As set forth in the CMA, SSA will 

provide CMS the following information 

when relevant: (1) Social Security 

number (SSN) verifications, (2) a death 

indicator, (3) an indicator of a finding of 

disability by SSA under title II of the 

Social Security Act, (4) prisoner data, 

(5) monthly and annual Social Security 

benefit information under title II of the 

Social Security Act, (6) quarters of 

coverage, and (7) confirmation that an 

allegation of citizenship is consistent 

with SSA records. 

DESCRIPTION OF RECORDS TO BE USED IN THE

MATCHING PROGRAM: 

The matching program will be 

conducted with data maintained by 

CMS in the Health Insurance Exchanges 

System (HIX), CMS System No. 09–70– 

0560, as amended, published at 78 FR 

8538 (Feb. 6, 2013), 78 FR 32256 (May 

29, 2013) and 78 FR 63211 (October 23, 

2013). 

The matching program will also be 

conducted with data maintained by SSA 

in the following SORs: 

• Master Files of SSN Holders and 

SSN Applications, SSA/OEEAS, 60– 

0058, 75 FR 82121 (December 29, 2010), 

as amended 78 FR 40542 (July 5, 2013); 

• Prisoner Update Processing System 

(PUPS), SSA/OPB, 60–0269, 64 FR 

11076 (March 8, 1999), as amended 72 

FR 69723 (December 10, 2007) and 78 

FR 40542 (July 5, 2013); 

• Master Beneficiary Record, SSA/

ORSIS, 60–0090, 71 FR 1826 (January 

11, 2006), as amended 72 FR 69723 

(December 10, 2007) and 78 FR 40542 

(July 5, 2013); 

• Earnings Recording and SelfEmployment Income System, SSA/

OEEAS, 60–0059, 71 FR 1819(January 

11, 2006), as amended 78 FR 40542 (July 

5, 2013). 

INCLUSIVE DATES OF THE MATCH: 

The CMP will become effective no 

sooner than 40 days after the report of 

the matching program is sent to OMB 

and Congress, or 30 days after 

publication in the Federal Register, 

whichever is later. The matching 

program will continue for 18 months 

from the effective date and may be 

extended for an additional 12 months 

thereafter, if certain conditions are met. 

[FR Doc. 2016–02527 Filed 2–8–16; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Tribal Consultation Meetings 

AGENCY: Office of Head Start (OHS), 

Administration for Children and 

Families, HHS. 

ACTION: Notice of meetings. 

SUMMARY: Pursuant to the Improving 

Head Start for School Readiness Act of 

2007, Public Law 110–134, notice is 

hereby given of three 1-day Tribal 

Consultation Sessions to be held 

between the Department of Health and 

Human Services (HHS), Administration 

for Children and Families, OHS 

leadership and the leadership of Tribal 

Governments operating Head Start 

(including Early Head Start) programs. 

The purpose of these Consultation 

Sessions is to discuss ways to better 

meet the needs of American Indian and 

Alaska Native children and their 

families, taking into consideration 

funding allocations, distribution 

formulas, and other issues affecting the 

delivery of Head Start services in their 

geographic locations [42 U.S.C. 9835, 

section 640(l)(4)]. 

DATES:

March 7, 2016, from 1:30 p.m. to 5:00 

p.m. 

June 8, 2016, from 1:30 p.m. to 5:00 p.m. 

August 8, 2016, from 1:00 p.m. to 5:00 

p.m. 

Locations: 

• March 7, 2016—Hotel Albuquerque at 

Old Town, 800 Rio Grande Blvd. NW., 

Albuquerque, New Mexico 87104. 

• June 8, 2016—Arlington Renaissance 

Capital View Hotel, 2800 South 

Potomac Avenue, Arlington, Virginia 

22202. 

• August 8, 2016—Northern Quest 

Resort & Casino, 100 North Hayford 

Road, Airway Heights, WA 99001. 

FOR FURTHER INFORMATION CONTACT: 

Angie Godfrey, Regional Program 

Manager, Region XI/AIAN, Office of 

Head Start, email Angie.Godfrey@

acf.hhs.gov, or phone (202) 205–5811. 

Additional information and online 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 6865 

meeting registration is available at: 

http://eclkc.ohs.acf.hhs.gov/hslc/hs/

calendar/tc2016. 

SUPPLEMENTARY INFORMATION: HHS 

announces OHS Tribal Consultations for 

leaders of Tribal Governments operating 

Head Start and Early Head Start 

programs. The agenda for the scheduled 

OHS Tribal Consultations in 

Albuquerque, New Mexico, Arlington, 

Virginia, and Spokane, Washington, will 

be organized around the statutory 

purposes of Head Start Tribal 

Consultations related to meeting the 

needs of American Indian and Alaska 

Native children and families, taking into 

consideration funding allocations, 

distribution formulas, and other issues 

affecting the delivery of Head Start 

services in their geographic locations. In 

addition, OHS will share actions taken 

and in progress to address the issues 

and concerns raised in the 2015 OHS 

Tribal Consultations. 

The Consultation Sessions will be 

conducted with elected or appointed 

leaders of Tribal Governments and their 

designated representatives [42 U.S.C. 

9835, section 640(l)(4)(A)]. Designees 

must have a letter from the Tribal 

Government authorizing them to 

represent the tribe. Tribal Governments 

must submit the designee letter at least 

3 days in advance of the Consultation 

Session to Angie Godfrey at 

Angie.Godfrey@acf.hhs.gov. Other 

representatives of tribal organizations 

and Native nonprofit organizations are 

welcome to attend as observers. 

A detailed report of each Consultation 

Session will be prepared and made 

available within 45 days of the 

Consultation Sessions to all Tribal 

Governments receiving funds for Head 

Start and Early Head Start programs. 

Tribes wishing to submit written 

testimony for the report should send 

testimony to Angie Godfrey at 

Angie.Godfrey@acf.hhs.gov either prior 

to each Consultation Session or within 

30 days after each meeting. OHS will 

summarize oral testimony and 

comments from the Consultation 

Session in each report without 

attribution, along with topics of concern 

and recommendations. 

Dated: February 2, 2016. 

Blanca E. Enriquez, 

Director, Office of Head Start. 

[FR Doc. 2016–02580 Filed 2–8–16; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket Nos. FDA–2015–M–3256, FDA– 

2015–M–3257, FDA–2015–M–3258, FDA– 

2015–M–3376, FDA–2015–M–3377, FDA– 

2015–M–3516, FDA–2015–M–3516, FDA– 

2015–M–3519, FDA–2015–M–3520, FDA– 

2015–M–3521, FDA–2015–M–4013, FDA– 

2015–M–4014, FDA–2015–M–4015, FDA– 

2015–M–4016, FDA–2015–M–4017, FDA– 

2015–M–4018, FDA–2015–M–4069, FDA– 

2015–M–4343, FDA–2015–M–4344, FDA– 

2015–M–4434, FDA–2015–M–4728, FDA– 

2015–M–4947, and FDA–2015–M–4951] 

Medical Devices; Availability of Safety 

and Effectiveness Summaries for 

Premarket Approval Applications 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is publishing a 

list of premarket approval applications 

(PMAs) that have been approved. This 

list is intended to inform the public of 

the availability of safety and 

effectiveness summaries of approved 

PMAs through the Internet and the 

Agency’s Division of Dockets 

Management. 

ADDRESSES: You may submit comments 

as follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to http://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on http://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand delivery/Courier (for 

written/paper submissions): Division of 

Dockets Management (HFA–305), Food 

and Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Division of Dockets 

Management, FDA will post your 

comment, as well as any attachments, 

except for information submitted, 

marked and identified, as confidential, 

if submitted as detailed in 

‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket Nos. FDA– 

2015–M–3256, FDA–2015–M–3257, 

FDA–2015–M–3258, FDA–2015–M– 

3376, FDA–2015–M–3377, FDA–2015– 

M–3516, FDA–2015–M–3516, FDA– 

2015–M–3519, FDA–2015–M–3520, 

FDA–2015–M–3521, FDA–2015–M– 

4013, FDA–2015–M–4014, FDA–2015– 

M–4015, FDA–2015–M–4016, FDA– 

2015–M–4017, FDA–2015–M–4018, 

FDA–2015–M–4069, FDA–2015–M– 

4343, FDA–2015–M–4344, FDA–2015– 

M–4434, FDA–2015–M–4728, FDA– 

2015–M–4947, and FDA–2015–M–4951 

for ‘‘Medical Devices; Availability of 

Safety and Effectiveness Summaries for 

Premarket Approval Applications.’’ 

Received comments will be placed in 

the docket and, except for those 

submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

http://www.regulations.gov or at the 

Division of Dockets Management 

between 9 a.m. and 4 p.m., Monday 

through Friday. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION’’. The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

http://www.regulations.gov. Submit 

both copies to the Division of Dockets 

Management. If you do not wish your 

name and contact information to be 

made publicly available, you can 

provide this information on the cover 

sheet and not in the body of your 

comments and you must identify this 

mstockstill on DSK4VPTVN1PROD with NOTICES